Summary Introduction: Why Peptide Characterization of Lanreotide Generic Project is Critical for USFDA Submission The Peptide Characterization of Lanreotide Generic […]
Peptide Characterization of Lanreotide Generic Project Submission to USFDA Read More »
Introduction: PLGA polymer characterization for generics represents one of the most challenging aspects of developing complex injectable drug products, yet
Introduction Ensuring a Nitrosamine-Free Manufacturing Process is no longer optional for pharmaceutical companies. Regulatory agencies across the world now expect
Introduction: Why Nitrosamine Testing for Peptides and Oligonucleotides Matters Now Nitrosamine Testing for Peptides and Oligonucleotides has become a critical
Introduction: Reverse engineering of PLGA polymer in Lupron Depot represents a scientifically rigorous and commercially critical pathway for pharmaceutical companies
Summary (Quick Takeaways) Introduction: Why Integrating Nitrosamine Testing for CDMO Is a Quality Imperative Integrating Nitrosamine Testing for CDMO into
Introduction: How API Synthesis Optimization to Reduce Nitrosamine Risk Works API Synthesis Optimization to reduce Nitrosamine Risk begins with designing
Introduction Understanding GC-MS method validation cost is critical for pharmaceutical, biotech, and CRO organizations planning analytical development projects. Method validation
Introduction to GC-MS Testing for Medical Devices GC-MS testing for medical devices is the most powerful analytical technique for detecting
GC-MS Testing for Medical Devices: Extractables & Leachables Requirements Explained Read More »
Introduction GC-MS analysis for pharmaceuticals is the gold standard technique for identifying and quantifying volatile and semi-volatile compounds in drug
